142 related articles for article (PubMed ID: 32589170)
1. Improved synergic therapeutic effects of chemoradiation therapy with the aid of a co-drug-loaded nano-radiosensitizer under conventional-dose X-ray irradiation.
Nosrati H; Charmi J; Abhari F; Attari E; Bochani S; Johari B; Rezaeejam H; Kheiri Manjili H; Davaran S; Danafar H
Biomater Sci; 2020 Aug; 8(15):4275-4286. PubMed ID: 32589170
[TBL] [Abstract][Full Text] [Related]
2. Multi-wall carbon Nanotube surface-based functional nanoparticles for stimuli-responsive dual pharmaceutical compound delivery.
Nabitabar M; Shaterian M; Danafar H; Enhessari M
Sci Rep; 2024 May; 14(1):12073. PubMed ID: 38802442
[TBL] [Abstract][Full Text] [Related]
3. Evaluation radioprotective effect of curcumin conjugated albumin nanoparticles.
Nosrati H; Danafar H; Rezaeejam H; Gholipour N; Rahimi-Nasrabadi M
Bioorg Chem; 2020 Jul; 100():103891. PubMed ID: 32422388
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
5. Facile green synthesis of bismuth sulfide radiosensitizer
Nosrati H; Abhari F; Charmi J; Rahmati M; Johari B; Azizi S; Rezaeejam H; Danafar H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3832-3838. PubMed ID: 31556316
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
7. Tumor Targeted Albumin Coated Bismuth Sulfide Nanoparticles (Bi
Nosrati H; Charmi J; Salehiabar M; Abhari F; Danafar H
ACS Biomater Sci Eng; 2019 Sep; 5(9):4416-4424. PubMed ID: 33438407
[TBL] [Abstract][Full Text] [Related]
8. Targeted CuFe
Salehiabar M; Ghaffarlou M; Mohammadi A; Mousazadeh N; Rahimi H; Abhari F; Rashidzadeh H; Nasehi L; Rezaeejam H; Barsbay M; Ertas YN; Nosrati H; Kavetskyy T; Danafar H
J Control Release; 2023 Jan; 353():850-863. PubMed ID: 36493951
[TBL] [Abstract][Full Text] [Related]
9. Iron oxide and gold bimetallic radiosensitizers for synchronous tumor chemoradiation therapy in 4T1 breast cancer murine model.
Nosrati H; Baghdadchi Y; Abbasi R; Barsbay M; Ghaffarlou M; Abhari F; Mohammadi A; Kavetskyy T; Bochani S; Rezaeejam H; Davaran S; Danafar H
J Mater Chem B; 2021 Jun; 9(22):4510-4522. PubMed ID: 34027529
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
11. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery.
Nosrati H; Abhari F; Charmi J; Davaran S; Danafar H
Bioorg Chem; 2019 Jul; 88():102959. PubMed ID: 31075743
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
16. Bovine serum albumin and folic acid-modified aurum nanoparticles loaded with paclitaxel and curcumin enhance radiotherapy sensitization for esophageal cancer.
Gao G; Zhou W; Jiang X; Ma J
Int J Radiat Biol; 2024; 100(3):411-419. PubMed ID: 37934908
[TBL] [Abstract][Full Text] [Related]
17. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
18. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
19. Complete ablation of tumors using synchronous chemoradiation with bimetallic theranostic nanoparticles.
Nosrati H; Attari E; Abhari F; Barsbay M; Ghaffarlou M; Mousazadeh N; Vaezi R; Kavetskyy T; Rezaeejam H; Webster TJ; Johari B; Danafar H
Bioact Mater; 2022 Jan; 7():74-84. PubMed ID: 34466718
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin.
Danafar H; Sharafi A; Askarlou S; Manjili HK
Drug Res (Stuttg); 2017 Dec; 67(12):698-704. PubMed ID: 28738425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
